Wolverine Trading’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $315K | Buy |
16,719
+2,819
| +20% | +$50.3K | ﹤0.01% | 4310 |
|
|
2025
Q2 | $238K | Sell |
13,900
-314
| -2% | -$13.4K | ﹤0.01% | 3718 |
|
|
2025
Q1 | $1M | Buy |
14,214
+4,257
| +43% | +$448K | ﹤0.01% | 2229 |
|
|
2024
Q4 | $1.21M | Sell |
9,957
-8,439
| -46% | -$1.03M | ﹤0.01% | 2476 |
|
|
2024
Q3 | $2.29M | Buy |
18,396
+3,396
| +23% | +$469K | ﹤0.01% | 1594 |
|
|
2024
Q2 | $2.37M | Sell |
15,000
-3,151
| -17% | -$405K | ﹤0.01% | 1484 |
|
|
2024
Q1 | $2.35M | Buy |
18,151
+9,225
| +103% | +$1.13M | ﹤0.01% | 1486 |
|
|
2023
Q4 | $861K | Sell |
8,926
-6,389
| -42% | -$613K | ﹤0.01% | 2435 |
|
|
2023
Q3 | $1.86M | Buy |
15,315
+6,033
| +65% | +$682K | ﹤0.01% | 1646 |
|
|
2023
Q2 | $1.04M | Sell |
9,282
-22,916
| -71% | -$2.95M | ﹤0.01% | 1981 |
|
|
2023
Q1 | $4.38M | Buy |
32,198
+21,881
| +212% | +$2.84M | 0.01% | 912 |
|
|
2022
Q4 | $1.34M | Buy |
10,317
+2,792
| +37% | +$324K | ﹤0.01% | 1641 |
|
|
2022
Q3 | $825K | Buy |
+7,525
| New | +$758K | ﹤0.01% | 2136 |
|
|
2022
Q1 | – | Sell |
-18,621
| Closed | -$1.43M | – | 6379 |
|
|
2021
Q4 | $1.69M | Sell |
18,621
-7,751
| -29% | -$663K | ﹤0.01% | 2048 |
|
|
2021
Q3 | $2.34M | Buy |
26,372
+9,429
| +56% | +$726K | ﹤0.01% | 1985 |
|
|
2021
Q2 | $1.33M | Sell |
16,943
-21,666
| -56% | -$1.64M | ﹤0.01% | 2454 |
|
|
2021
Q1 | $2.82M | Buy |
38,609
+12,641
| +49% | +$1.17M | ﹤0.01% | 1594 |
|
|
2020
Q4 | $4.46M | Buy |
+25,968
| New | +$3.85M | 0.01% | 1144 |
|
|
2020
Q3 | – | Sell |
-26,001
| Closed | -$3.95M | – | 5108 |
|
|
2020
Q2 | $4.23M | Buy |
26,001
+3,088
| +13% | +$420K | 0.01% | 908 |
|
|
2020
Q1 | $2.26M | Buy |
+22,913
| New | +$2.62M | 0.01% | 1256 |
|
|
2019
Q1 | – | Sell |
-56,693
| Closed | -$7.29M | – | 5271 |
|
|
2018
Q4 | $6.12M | Buy |
56,693
+2,248
| +4% | +$281K | 0.02% | 691 |
|
|
2018
Q3 | $8.79M | Buy |
54,445
+51,640
| +1,841% | +$7.06M | 0.02% | 627 |
|
|
2018
Q2 | $208K | Hold |
2,805
| – | – | ﹤0.01% | 4330 |
|
|
2018
Q1 | $208K | Sell |
2,805
-41,411
| -94% | -$2.76M | ﹤0.01% | 4330 |
|
|
2017
Q4 | $2.46M | Sell |
44,216
-30,902
| -41% | -$1.64M | 0.01% | 1377 |
|
|
2017
Q3 | $3.41M | Buy |
75,118
+5,658
| +8% | +$226K | 0.01% | 1000 |
|
|
2017
Q2 | $2.32M | Sell |
69,460
-27,715
| -29% | -$902K | 0.01% | 1147 |
|
|
2017
Q1 | $2.82M | Buy |
+97,175
| New | +$3.01M | 0.02% | 952 |
|
|
2016
Q4 | – | Sell |
-43,206
| Closed | -$1.74M | – | 5091 |
|
|
2016
Q3 | $2.63M | Buy |
+43,206
| New | +$1.31M | 0.01% | 1125 |
|
Other funds holding SRPT
EAM
Wolverine Trading's SRPT Position: Q3 2025 in Review
Wolverine Trading increased its Sarepta Therapeutics (SRPT) stake by 20% in Q3 2025, buying an estimated $50.3K and bringing the position to 16,719 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #4310.
Wolverine Trading first reported a position in SRPT in Q3 2016 and has held it in 29 quarters since. The position peaked at $8.79M in Q3 2018. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.
- Wolverine Trading held 16,719 shares of Sarepta Therapeutics worth $315K as of Q3 2025.
- Wolverine Trading bought 2,819 Sarepta Therapeutics shares in Q3 2025, an estimated $50.3K.
- Sarepta Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4310 holding.
- Wolverine Trading first reported a position in Sarepta Therapeutics in Q3 2016 and has held it in 29 quarters since.
- Wolverine Trading's Sarepta Therapeutics position peaked at $8.79M in Q3 2018.
- 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.